Summary
The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin ], enoxaparin [Lovenox ]) and factor Xa inhibitors (fondaparinux [Arixtra ]).In general, the injectable anticoagulants are Food and Drug Administration (FDA)-approved for prophylaxis and/or treatment of venous thromboembolism.
The global Injectable Anticoagulants market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major Application
Global market size by Major Type
Key manufacturers are included based on company profile, sales data and product specifications etc.:
Genentech (Roche)
Sanofi
Boehringer Ingelheim
Pfizer
The Medicines Company
Aspen
Otsuka
Major applications as follows:
VTE
ACS/MI
AF
Others
Major Type as follows:
Low-molecular-weight Heparin (LMWH)
Direct Thrombin Inhibitor (DTI)
Others
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Table of Contents
1 Global Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Type
1.1.5 Scope of Regions/Countries
1.2 Global Market Size
2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 Key Manufacturers
3.1 Genentech (Roche)
3.1.1 Company Information
3.1.2 Product & Services
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.1.4 Recent Development
3.2 Sanofi
3.2.1 Company Information
3.2.2 Product & Services
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2.4 Recent Development
3.3 Boehringer Ingelheim
3.3.1 Company Information
3.3.2 Product & Services
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3.4 Recent Development
3.4 Pfizer
3.4.1 Company Information
3.4.2 Product & Services
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4.4 Recent Development
3.5 The Medicines Company
3.5.1 Company Information
3.5.2 Product & Services
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5.4 Recent Development
3.6 Aspen
3.6.1 Company Information
3.6.2 Product & Services
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Otsuka
3.7.1 Company Information
3.7.2 Product & Services
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 Major Application
4.1 VTE
4.1.1 Overview
4.1.2 VTE Market Size and Forecast
4.2 ACS/MI
4.2.1 Overview
4.2.2 ACS/MI Market Size and Forecast
4.3 AF
4.3.1 Overview
4.3.2 AF Market Size and Forecast
4.4 Others
4.4.1 Overview
4.4.2 Others Market Size and Forecast
5 Market by Type
5.By Low-molecular-weight Heparin (LMWH)
5.1 Low-molecular-weight Heparin (LMWH)
5.1.1 Overview
5.1.2 Low-molecular-weight Heparin (LMWH) Market Size and Forecast
5.2 Direct Thrombin Inhibitor (DTI)
5.2.1 Overview
5.2.2 Direct Thrombin Inhibitor (DTI) Market Size and Forecast
5.3 Others
5.3.1 Overview
5.3.2 Others Market Size and Forecast
6 Price Overview
6.1 Price by Manufacturers
6.2 Price by Application
6.3 Price by Type
7 Conclusion
Fig Global Injectable Anticoagulants Market Size and CAGR 2013-2018 (Million USD)
Fig Global Injectable Anticoagulants Market Size and CAGR 2013-2018 (Volume)
Fig Global Injectable Anticoagulants Market Forecast and CAGR 2019-2025 (Million USD)
Fig Global Injectable Anticoagulants Market Forecast and CAGR 2019-2025 (Volume)
Fig VTE Market Size and CAGR 2013-2018 (Million USD)
Fig VTE Market Size and CAGR 2013-2018 (Volume)
Fig VTE Market Forecast and CAGR 2019-2025 (Million USD)
Fig VTE Market Forecast and CAGR 2019-2025 (Volume)
Fig ACS/MI Market Size and CAGR 2013-2018 (Million USD)
Fig ACS/MI Market Size and CAGR 2013-2018 (Volume)
Fig ACS/MI Market Forecast and CAGR 2019-2025 (Million USD)
Fig ACS/MI Market Forecast and CAGR 2019-2025 (Volume)
Fig AF Market Size and CAGR 2013-2018 (Million USD)
Fig AF Market Size and CAGR 2013-2018 (Volume)
Fig AF Market Forecast and CAGR 2019-2025 (Million USD)
Fig AF Market Forecast and CAGR 2019-2025 (Volume)
Fig Others Market Size and CAGR 2013-2018 (Million USD)
Fig Others Market Size and CAGR 2013-2018 (Volume)
Fig Others Market Forecast and CAGR 2019-2025 (Million USD)
Fig Others Market Forecast and CAGR 2019-2025 (Volume)
Fig Low-molecular-weight Heparin (LMWH) Market Size and CAGR 2013-2018 (Million USD)
Fig Low-molecular-weight Heparin (LMWH) Market Size and CAGR 2013-2018 (Volume)
Fig Low-molecular-weight Heparin (LMWH) Market Forecast and CAGR 2019-2025 (Million USD)
Fig Low-molecular-weight Heparin (LMWH) Market Forecast and CAGR 2019-2025 (Volume)
Fig Direct Thrombin Inhibitor (DTI) Market Size and CAGR 2013-2018 (Million USD)
Fig Direct Thrombin Inhibitor (DTI) Market Size and CAGR 2013-2018 (Volume)
Fig Direct Thrombin Inhibitor (DTI) Market Forecast and CAGR 2019-2025 (Million USD)
Fig Direct Thrombin Inhibitor (DTI) Market Forecast and CAGR 2019-2025 (Volume)
Fig Others Market Size and CAGR 2013-2018 (Million USD)
Fig Others Market Size and CAGR 2013-2018 (Volume)
Fig Others Market Forecast and CAGR 2019-2025 (Million USD)
Fig Others Market Forecast and CAGR 2019-2025 (Volume)